6505--Averitas Pharma, Inc., 65IB, 36F79725D0245 Performance Period: 09/29/2025 - 09/28/2030 36F79725D0245
Summary
AI-generated · Sep 29, 2025Awarded contract to Averitas Pharma, Inc. for $19,239,160, spanning a five-year performance period starting in late September 2025 and ending in late September 2030. The notice does not include a description of the required work, scope, or any specific or unique requirements such as certifications or site visits.
Notice history
1-
Award Notice LATEST Posted Sep 24, 2025
Details
Award Information
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| AVERITAS PHARMA, INC | QU48MTF1KBT5 | 85WE5 | MORRISTOWN |
Contacts
VA Federal Supply Schedule (FSS) Service
Phone